Efficacy and Safety of Cabozantinib in Patients With Hepatocellular Carcinoma
Condition(s):HepatocarcinomaLast Updated:June 17, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):HepatocarcinomaLast Updated:June 17, 2020Unknown status
Condition(s):Osteosarcoma; Ewing Sarcoma; Rhabdomyosarcoma; Relapsed Pediatric Solid Tumor; Refractory Pediatric Solid Tumor; Melanoma; Hepatoblastoma; Hepatocellular Carcinoma; Neuroblastoma; Wilms TumorLast Updated:September 5, 2023Active, not recruiting
Condition(s):Malignant MelanomaLast Updated:April 8, 2019Unknown status
Condition(s):Nasopharyngeal Carcinoma; Maintenance TherapyLast Updated:May 22, 2023Recruiting
Condition(s):Head and Neck CancerLast Updated:January 31, 2024Recruiting
Condition(s):Colorectal Cancer MetastaticLast Updated:August 14, 2023Suspended
Condition(s):Carcinoma, Hepatocellular; Hepatic Carcinoma; Hepatocellular CancerLast Updated:July 20, 2023Completed
Condition(s):MelanomaLast Updated:October 18, 2021Completed
Condition(s):Adult Solid TumorLast Updated:February 6, 2024Completed
Condition(s):Urothelial Carcinoma Recurrent; Advanced Urothelial CarcinomaLast Updated:September 24, 2021Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.